Xiao T. Niu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain.
Journal: Emerging microbes & infections
Published: October 03, 2024
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1.
Journal: Nature
Published: June 18, 2024
Antigenicity assessment of SARS-CoV-2 saltation variant BA.2.87.1.
Journal: Emerging microbes & infections
Published: April 15, 2024
Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure.
Journal: The Lancet. Infectious diseases
Published: November 14, 2023
Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455-456 synergistically enhances antibody evasion and ACE2 binding.
Journal: PLoS pathogens
Published: October 24, 2023
Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86.
Journal: The Lancet. Infectious diseases
Published: September 04, 2023
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting.
Journal: Nature
Published: May 02, 2023
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution.
Journal: Nature
Published: September 23, 2022
Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75.
Journal: Cell host & microbe
Published: August 15, 2022
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
Journal: Nature
Published: April 30, 2022
Last Updated: 09/26/2026